Contents9 sections
Bioregulators are short peptides and organ-derived peptide extracts that Russian researchers say help specific tissues, such as the thymus, the pineal gland or the blood vessels, work as they should. The idea comes from Professor Vladimir Khavinson and his colleagues in St. Petersburg, who started with peptide extracts from animal organs in the 1970s and later made synthetic versions only two to four amino acids long, such as Thymogen, Vilon, Epitalon and Testagen.
These compounds now turn up in anti-aging and biohacking circles, mostly through research-peptide vendors. The evidence has not kept pace with the marketing. Most of the human data come from small Russian studies run by the developers, and much of the rest is cell and animal work.
This guide explains what bioregulators are and are not, how they are thought to work, the best-known examples, the doses used in Russian practice, what the research shows and what is still unknown about safety.
Key Takeaways
- “Bioregulators” means two things: short synthetic peptides of two to four amino acids from Vladimir Khavinson’s group, and peptide extracts from animal organs (cytomedins) such as Thymalin.
- They are said to act on specific organs by changing gene activity, but that mechanism comes almost entirely from cell and animal studies by the same research group.
- Thymogen and Thymalin are registered medicines in Russia with set doses; Vilon, Testagen, Epitalon and most others are unapproved research compounds with no studied human dose.
- Human evidence is limited to small, mostly Russian studies, often without a placebo group, and has rarely been checked by independent researchers.
- Short courses appear well tolerated in the reports available, but long-term safety has never been tested, so “few reported side effects” does not mean proven safe.
What Are Bioregulators?
In the research literature, “peptide bioregulators” are short peptides that are proposed to regulate the function of the tissue they were first isolated from, or were designed to target. The term is not a recognized drug class in Western medicine. It is used mainly in Russian research and by the companies that sell these products.
The concept was developed by Vladimir Khavinson, first at the Military Medical Academy in Leningrad (now St. Petersburg) and later at the St. Petersburg Institute of Bioregulation and Gerontology. With his colleague Vladimir Morozov, he isolated peptide mixtures from calf thymus and pineal gland, which became Thymalin and Epithalamin. The group later identified very short peptides that they believe carry much of the extracts’ activity, and made them synthetically.
Some websites stretch the word “bioregulator” to cover hormones, herbal adaptogens such as ashwagandha or rhodiola, and nootropics such as phenibut. That is not how the term is used in the research, and those compounds work in entirely different ways. This guide sticks to the peptide meaning.
Two Kinds of Bioregulators
Peptide bioregulators fall into two groups:
- Organ peptide extracts (cytomedins). Mixtures of short peptides purified from animal organs, usually from calves. Thymalin (from the thymus) and Epithalamin (from the pineal gland) are the best-known examples.
- Synthetic short peptides. Lab-made chains of two to four amino acids that copy a sequence thought to be active, for example Thymogen (Glu-Trp), Vilon (Lys-Glu) and Epitalon (Ala-Glu-Asp-Gly). They are single, defined molecules, and much of the research on peptide bioregulators and aging focuses on them.
What Bioregulators Are Claimed to Do
Khavinson’s group credits peptide bioregulators with these effects:
- Shifting gene expression in the target tissue toward a younger pattern
- Normalizing immune function (thymus peptides such as Thymalin, Thymogen and Vilon)
- Restoring the pineal gland’s melatonin rhythm in older animals (Epithalamin and Epitalon)
- Supporting repair and function in aging organs such as the heart, liver, brain and blood vessels
These claims come mainly from cell cultures and animal studies run by the developers. The human evidence is much thinner and is covered below.
How They Are Thought to Work
The proposed mechanism is unusual. Khavinson’s group argues that ultrashort peptides are small enough to enter cells and reach the nucleus, where they bind to specific stretches of DNA or to histone proteins. In their cell studies, this changes how tightly the DNA is packed and switches particular genes on or off, for example genes for tissue-specific proteins that tend to decline with age.
It is an interesting hypothesis, but it is still a hypothesis. Nearly all of the mechanistic work comes from one research group and its collaborators, and independent labs have done little to repeat it. It is also not clear how a peptide only two to four amino acids long could recognize one specific gene. Treat the “organ-specific” label as the developers’ claim, not an established fact.
The Best-Known Peptide Bioregulators
Khavinson’s group has developed dozens of short peptides, most of them named after the organ they are meant to target. The table lists the ones discussed most often, with their amino acid sequences. Our guides and compound profiles cover each one in more detail.
| Peptide | Sequence | Target (as described by the developers) |
|---|---|---|
| Thymogen | Glu-Trp | Thymus and immune system |
| Thymalin | Thymus peptide extract | Thymus and immune system |
| Vilon | Lys-Glu | Immune system, aging tissue |
| Epitalon | Ala-Glu-Asp-Gly | Pineal gland |
| Testagen | Lys-Glu-Asp-Gly | Testes |
| Cardiogen | Ala-Glu-Asp-Arg | Heart muscle |
| Vesugen | Lys-Glu-Asp | Blood vessels |
| Ovagen | Glu-Asp-Leu | Liver and digestive tract |
| Livagen | Lys-Glu-Asp-Ala | Liver |
| Pancragen | Lys-Glu-Asp-Trp | Pancreas |
| Pinealon | Glu-Asp-Arg | Brain |
| Cortagen | Ala-Glu-Asp-Pro | Brain cortex and nerves |
| Bronchogen | Ala-Glu-Asp-Leu | Bronchi and lungs |
| Chonluten | Glu-Asp-Gly | Airway lining |
| Prostamax | Lys-Glu-Asp-Pro | Prostate |
| Cartalax | Ala-Glu-Asp | Cartilage |
Three of these come up most often in the West and are covered below in more detail: Thymogen, Testagen and Vilon.
Thymogen
Thymogen is a synthetic dipeptide, glutamyl-tryptophan (Glu-Trp), that Khavinson’s group identified as an active component of the thymus extract Thymalin. It is a registered immunomodulator in Russia, where it is used in short courses for infections and for recovery after illness or surgery.
The same dipeptide was later tested in the United States as IM862 (oglufanide) for AIDS-related Kaposi’s sarcoma, and it did not show a meaningful benefit in a phase III trial.
- Form: intramuscular injection in Russian practice (also a nasal spray and a cream); research vials are sold as freeze-dried powder
- Dose used in Russian practice: 50-100 mcg (micrograms) once daily
- Course: 3-10 days, not months
- Evidence: small, mostly open-label Russian clinical studies of immune support; no trials in healthy people or athletes
- Side effects: reported as well tolerated in short courses; injection-site reactions are possible; no long-term data
Testagen
Testagen is a synthetic tetrapeptide (Lys-Glu-Asp-Gly) from Khavinson’s group, sold as a bioregulator for the testes and male reproductive function. Vendors also market it for hormone balance and energy, but no human study backs those claims.
Published research on this peptide is sparse, mostly cell experiments from the developers, and there are no controlled human trials. That means there is no studied human dose. The figures that circulate online come from vendor and forum protocols, not from research.
- Form: freeze-dried powder for injection (research vials)
- Studied human dose: none
- Evidence: cell studies; no controlled human trials
- Side effects: not studied in controlled trials
Vilon
Vilon is a synthetic dipeptide (Lys-Glu) and one of the most studied of Khavinson’s short peptides. In cell studies, his group reports that it loosens tightly packed chromatin and reactivates gene expression in cells from older people. Rodent studies from the same group and its collaborators report effects on immune function and lifespan.
There are no large controlled human trials, so there is no established human dose. Our Vilon guide covers the research and the protocols reported online in more detail.
- Form: freeze-dried powder for injection (research vials)
- Studied human dose: none established
- Evidence: cell and rodent studies, mostly from the developers
- Side effects: not studied in controlled trials
Outside Russia, Thymogen, Testagen and Vilon are sold as research peptides labeled “not for human use”, so quality depends entirely on the seller. If you look into a supplier, ask for a batch-specific certificate of analysis from an independent lab; our guide on how to read a peptide COA explains what to check. A clean COA confirms identity and purity, not that a peptide is safe or effective.
Pros
- Exceptional purity & testing (≥98%)
- Pharmaceutical-style packaging for stability
- Broad catalog across peptides & nootropics
- Strong reputation & consistency across years
Cons
- Some items frequently out of stock due to high demand
- Limited long-term data for some compounds
Cardiogen, Ovagen, Epitalon and the Rest
Cardiogen (Ala-Glu-Asp-Arg) is described as a bioregulator for heart muscle. The research behind it is cell and animal work.
Ovagen (Glu-Asp-Leu) is marketed for the liver and digestive tract, again on the basis of preclinical data.
Epitalon (Ala-Glu-Asp-Gly) was modeled on the pineal extract Epithalamin. It is studied mainly as a telomerase activator: in human cell cultures it switched on telomerase and lengthened telomeres, and rodent studies linked it to longer life. The human data come from small Russian studies, many of which used Epithalamin rather than Epitalon.
Overview
- Form: Lyophilized powder for subcutaneous injection
- Researched Dosage: 5 mg to 10 mg daily reported; conservative protocols use 100 mcg to 500 mcg daily
- Typical Cycle: 10-20 days, repeated 1-2 times per year
- Cost: $29.99 to $89.99 (varies by supplier)
- Stacking Options: Thymalin, GHK-Cu, NAD+
Pros
- A synthetic four-amino-acid peptide (AEDG) based on epithalamin, an extract of the pineal gland.
- Cell studies found it activated telomerase and lengthened telomeres, the chromosome caps linked to cellular aging.
- Russian studies in older adults reported better melatonin rhythms and other markers of healthy aging.
Cons
- Most of the research comes from one Russian group and has not been independently replicated.
- Turning on telomerase raises a theoretical concern, since cancer cells use it to keep dividing.
- It is not an approved human medication, and its long-term safety in people is unknown.
The other organ-named peptides in the table, from Pinealon to Cartalax, follow the same pattern: a clearly claimed target, supporting cell and animal studies, and very little independent human data.
Doses Used in Russian Practice and Research
Only the two thymus products have established doses, because they are registered medicines in Russia. For the synthetic research peptides, no human dose has been defined in trials. The figures below describe what has been used, not a recommendation.
| Peptide | Dose used | Route | Course | Source of the figure |
|---|---|---|---|---|
| Thymogen | 50-100 mcg once daily | Intramuscular injection | 3-10 days | Russian clinical practice |
| Thymalin | 5-20 mg (usually 10 mg) once daily | Intramuscular injection | 3-10 days | Russian clinical practice |
| Testagen | Not established | Injection (research vials) | Not established | Vendor and forum protocols only |
| Vilon | Not established | Injection (research vials) | Not established | Vendor and forum protocols only |
| Epitalon | Not established | Injection (research vials) | Not established | Vendor protocols; the Russian human studies mostly used Epithalamin |
Watch the units. Thymogen is dosed in micrograms (mcg) and Thymalin in milligrams (mg). One milligram is 1,000 micrograms, so mixing the two up is a 1,000-fold error.
Vendor and Russian supplement protocols for the synthetic bioregulators describe short courses, typically 10-20 days and sometimes repeated a few times a year, rather than continuous use. Our peptide dosage chart lists studied doses and routes for other peptides.
What the Research Actually Shows
Khavinson’s group has published a large body of work over several decades. Read closely, it falls into three tiers:
- Cell and animal studies, the large majority: gene-activity and chromatin changes in cultured cells, and lifespan, tumor and immune studies in mice and rats.
- Small Russian clinical studies, mainly of Thymalin and Thymogen as immune treatments, often open-label and without a placebo group.
- Long-term follow-ups of older adults in St. Petersburg. The best known reported lower death rates over several years in people given courses of Thymalin and Epithalamin than in untreated controls. The study was small, was run by the developers and has not been independently repeated.
What is missing matters just as much: large randomized, placebo-controlled trials, replication by independent labs, and any studies in healthy younger adults or athletes. Much of the literature on peptide bioregulators, including the review articles, comes from the developers and their collaborators.
| Claimed benefit | Peptides usually named | Strength of evidence |
|---|---|---|
| Immune support | Thymalin, Thymogen, Vilon | Small Russian clinical studies for Thymalin and Thymogen; cell and animal data for Vilon |
| Slower aging, longer life | Epitalon, Epithalamin, Thymalin, Vilon | Rodent lifespan studies; small Russian studies in older adults |
| Brain and nerve health | Pinealon, Cortagen | Cell and animal studies |
| Heart and blood vessels | Cardiogen, Vesugen | Cell and animal studies |
| Lungs and airways | Bronchogen, Chonluten | Cell and animal studies |
| Muscle, hormones, performance | Testagen and others | No meaningful human data |
Claims that bioregulators improve mood, stress, anxiety, focus or “mental clarity” in healthy people have no controlled human evidence behind them.
Safety: What Is Known and What Is Not
The thymus products have the longest track record. Thymalin and Thymogen have been used in short courses in Russian clinical practice for many years, and published reports describe few side effects. For the synthetic research peptides, side effects have not been studied in controlled trials; redness or soreness at the injection site is the most commonly reported problem.
That is not the same as being proven safe. Claims that bioregulators have “no known toxicity” or are “safe for long-term use” go beyond the data:
- No controlled study has followed people using them long term.
- There are no data in pregnancy or breastfeeding, or for people with autoimmune disease or cancer.
- Epitalon activates telomerase in cell studies. Telomerase is also active in most cancers, and the long-term effect of switching it on in people is unknown.
- Research-grade vials are not made under pharmaceutical controls, so purity, real dose and sterility depend on the seller.
If you have a medical condition, take prescription medicines or are considering any peptide, talk to a doctor first.
The Bottom Line
Bioregulators are a real field of Russian peptide research, but the claims made for them run well ahead of the evidence.
- The term means Khavinson’s short synthetic peptides and organ extracts such as Thymalin, not herbs, hormones or nootropics.
- Thymogen and Thymalin have a history of short-course clinical use in Russia. Most others, including Vilon, Testagen and Epitalon, rest on cell and animal studies and small studies from the developers.
- Short courses appear well tolerated, but long-term safety, human dosing and benefits in healthy people are unproven. Talk to a doctor, and treat research-grade products with caution.
Frequently Asked Questions
Disclaimer
Please read carefully
The information on this site is for educational and informational purposes only, and is not medical advice. Always consult a qualified healthcare professional before using any supplement or medication, or making changes to your health, fitness, or nutrition routine.
Not medical advice
Content here is not a substitute for professional medical advice.
Consult your doctor
Talk to your doctor before starting any supplement or new routine.
Use at your own risk
We are not responsible for adverse effects from acting on this.
Do your research
Make informed decisions about your own health.
No guarantees
Individual results vary. No claims about outcomes.
Important — Never disregard professional medical advice or delay seeking it because of something you read here. If you think you may have a medical emergency, call your doctor or your local emergency number right away.
